Decisions Home

United States Artificial Organs & Bionics Market Insight

Published: 05 June 2026   |   Report Format: Electronic (PDF)

The United States Artificial Organs & Bionics Market is projected to grow at a CAGR of 9.8%, driven by rising prevalence of organ failure, increasing adoption of advanced prosthetics, growing demand for implantable medical devices, and continuous technological advancements in bionic systems.

United States Artificial Organs & Bionics Market Forecasts to 2035

  • The United States Artificial Organs & Bionics Market Size was Estimated at USD 12.46 Billion in 2025.
  • The Market Size is Expected to Grow at a CAGR of around 9.8% from 2025 to 2035.
  • The United States Artificial Organs & Bionics Market Size is Expected to Reach around USD 31.77 Billion by 2035.

 

Notable Insights in the United States Artificial Organs & Bionics Market

  • Segmentation Based on Product Type, the Artificial Organs segment held a dominant position in the United States Artificial Organs & Bionics Market in 2025 with nearly 61.8% share, driven by increasing utilization of artificial kidneys, ventricular assist devices, and artificial heart technologies.
  • Segmentation Based on Technology, Mechanical Bionics, Electronic Bionics, and Implantable Artificial Organs collectively accounted for approximately 69.4% share in 2025, supported by advancements in biomaterials, robotics, and neuroprosthetic integration.
  • The United States Artificial Organs & Bionics Market is driven by Medtronic plc, Abbott Laboratories, and Zimmer Biomet Holdings, Inc., with combined revenues of approximately USD 103.71 billion in 2025. The market is expected to grow at a CAGR of 9.8%.
  • Rising demand for advanced prosthetic limbs, increasing organ transplant shortages, and growing adoption of implantable assistive technologies are expected to drive market growth, with bionic device adoption increasing by approximately 12% annually across rehabilitation centers and specialty hospitals.

 

Download the eBook (ToC)

We value your privacy.

What Makes Decisions Advisors Research Unique?

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States artificial organs & bionics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in the United States Artificial Organs & Bionics Market

 

Recent Developments:

 

Market Segmentation:

United States Artificial Organs & Bionics Market, By Product Type

United States Artificial Organs & Bionics Market, By Technology

United States Artificial Organs & Bionics Market, By Application

United States Artificial Organs & Bionics Market, By End User

United States Artificial Organs & Bionics Market, By Distribution Channel

Direct Sales

 

Expert Views:

The United States Artificial Organs & Bionics Market is expected to witness significant growth through 2035, supported by advancements in implantable medical technologies, increasing demand for organ replacement solutions, and continuous innovation in robotic and neuroprosthetic systems. Strategic collaborations and product launches are anticipated to strengthen market expansion while enhancing patient mobility, functionality, and quality of life.


Author: Govind and Krishna By Spherical Insights and Consulting